Skip to main content
Caplight Logo









64x Bio

64x Bio

Private
Brisbane, CaliforniaHealthcare & Life Scienceshttps://64xbio.com/

Last Round

Series A

Jan 19, 2022

Est. Valuation

$2.14M

Total Funding Raised

$59.62M

Momentum

Top 25%

of companies Caplight tracks

Company Overview

64x Bio is a biotechnology company that develops a high-throughput mammalian cell line discovery platform to optimize cell line design for biomanufacturing and therapeutic applications.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Drug Discovery, Biotech Equipment

Business Model

B2B

Customer Profile

Services & Consulting, Data as a Service

AI Layer

Application

Keywords

adeno-associated virusAAVgene therapy manufacturingcell line developmentviral vector productionbiomanufacturingsynthetic biologysynbiobiotech platformCDMOcontract manufacturinghigh-throughput screeninggenomic engineeringbiotech R&Dcomputational biology

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

64x Bio Comparables

Compare 64x Bio with similar companies based on industry and business-model similarity.

64x Bio comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
NewBiologix
88%
Asimov
83%
Virica Biotech
73%

64x Bio Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Series AJan 19, 2022
SeedNov 16, 2020
AcceleratorAug 1, 2018

Key People

Founding team and executive leadership

Lexi Rovner

Co-founder & CEO

Founding Team

Michele Giovenelli

Chief Financial Officer

Executive Team

64x Bio Investors

Notable investors and investment history

64x Bio investors
InvestorRounds
Refactor CapitalSeries A, Seed
Future VenturesSeries A
SV AngelSeries A
Alix VenturesSeries A
Lifeforce CapitalSeries A
Northpond VenturesSeries A
First Round CapitalSeries A, Seed

Market signals

Structured signals derived from secondary market and firmographic data.

  • Jun 18, 2026

    Monthly visitors increased 1719% MoM, reaching 3.1K.

  • Jan 19, 2022

    $55M round led by Lifeforce Capital.

64x Bio Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

64x Bio Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about 64x Bio's valuation, stock price, and market status.

Firmographic Details

HeadquartersBrisbane, California
Employee Range20
Year Founded2017
Last FundingJan 19, 2022

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?